Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
M9466 + Tuvusertib for Cancer
Recruiting1 awardPhase 1
New York, New York
This trial is testing the safety, effectiveness, and how the body processes a drug called M9466 when used alone or with another drug called tuvusertib in people with advanced solid tumors.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service